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in a Yorkshire Terrier Bitch
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ABSTRACT
Background: Hyperadrenocorticism (HAC), is considered a set of symptoms due to excessive exposure to cortisol. Natu-
rally occurring HAC is most often related to pituitary tumors (pituitary-dependent HAC - PDH). Occult HAC, is referred 
as a clinical picture highly consistent with HAC; however, routine screening tests are negative. In addition, one or more 
steroids are elevated following administration of adrenocorticotrophic hormone (ACTH). Ovarian granulosa cell tumors, 
can produce steroids leading to paraneoplastic syndromes. The objective of this study was to report an unpublished case 
of ovarian granulosa cell tumor associated with occult hyperadrenocorticism in a Yorkshire Terrier.
Case: A 13-year-old intact female dog, Yorkshire Terrier, was brought for consultation with slight weight loss, polyuria, 
polydipsia, irregular estrous cycles, increased abdominal volume and thin coat. On physical examination the animal was 
gasping and presented severe periodontal disease, bulging abdomen, alopecia and skin hyperpigmentation. Complete 
blood count presented no changes; however, serum biochemistry evaluation highlighted hyperalbuminemia, hypertriglyc-
eridemia, alkaline phosphatase increased activity, and urinary specific gravity and creatinine below reference values. On 
abdominal ultrasonography left adrenal gland measured 2.08 cm x 1.08 cm and the right adrenal gland measured 2.11 cm 
x 0.84 cm, indicating bilateral adrenomegaly compatible with PDH. In the hypogastric abdomen, a large heterogeneous 
hypoechogenic mass was also observed, with areas of cystic cavities, measuring 5.80 cm x 7.30 cm. A low dose dexa-
methasone suppression test (LDDST) was performed, due to PDH suspicion. The test did not confirm HAC, suspecting, 
then, to be a case of occult/atypical HAC. Due to the strong clinical suspicion, and owner financial problems for further 
investigated occult HAC, trilostane treatment was initiated. Approximately one month after starting treatment, an ACTH 
stimulation test (AST) for cortisol and 17-hydroxyprogesterone (17-OHP) determination was performed, revealing high 
values for both hormones. Exploratory laparotomy was indicated due to the tumor image on hypogastric region visualized 
on abdominal ultrasonography. A cranial pole mass of the left ovary measuring 8.5 x 7.0 x 4.5 cm, of friable consistency 
and brownish color, was removed through ovariohysterectomy. A granulosa cell tumor on left ovary, as well as leiomyoma 
and cystic endometrial hyperplasia in the uterus, became clear through histopathological examination. Trilostane treatment 
was sustained after surgery. Few weeks later, the patient presented a clinical picture suggestive of hypoadrenocorticism, 
associated with a low sodium:potassium ratio (25:1), and AST results (basal and post-ACTH cortisol) below reference 
range, confirming Addisonian´ crises.  The patient deceives within two days.
Discussion: Granulosa cell tumors can produce estrogen and progesterone, as well as other steroids, leading to paraneoplastic 
syndromes with peculiar clinical presentations. Steroids transport in plasma occurs via specific carrier proteins. Increased 
production of other steroid hormones may result in higher concentration of free cortisol, thus leading to clinical manifesta-
tions of hypercortisolism. As 17-OHP is one of the precursors in cortisol synthesis and has been shown elevated on AST, 
it can be assumed that altered steroid hormone levels due to the granulosa cell tumor interfered on cortisol biodisponibil-
ity, leading to HAC signs. Dexamethasone suppression test results indicated that pituitary-adrenal axis was responsive to 
negative feedback. The Addisonian crises after tumor removal indicate that the main source for systemic excessive cortisol 
effects was the eminent steroid secretion by the granulosa cell tumor.    
Keywords: ovarium tumor, Cushing’s syndrome, atypical hyperadrenocorticism, steroidogenesis.
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INTRODUCTION
Hyperadrenocorticism (HAC), also called 
Cushing’s syndrome, is considered on of the most 
prevalent dogs’ endocrinopathies [3,15,16], and is 
defined as a myriad of clinical signs resultant of cor-
tisol effects’ excessive exposure [7]. Closely 80% of 
naturally occurring HAC cases results of excessive 
adrenocorticotrophic hormone (ACTH) by pituitary 
corticotrophinomas, being characterized as pituitary-
-dependent HAC (PDH). The last 15 to 20% of the 
cases are referred to functional adrenocortical tumors, 
ACTH-independent [7,8]. A less common spontaneous 
HAC cause is the atypical/occult form; followed by 
even lesser usual forms such as ectopic ACTH syndro-
me, food-dependent HAC, and adrenocortical tumor 
sexual hormones over secretion [8,13]
Occult HAC, also called atypical, is referred as 
a clinical picture highly consistent with HAC (clinical 
signals, hematology, serum biochemistry, urinalysis, 
and ultrasound); however, routine screening tests 
are negative, such as the low dose dexamethasone 
suppression test (LDDST) and ACTH stimulation test 
(AST). In addition, one or more steroids are elevated 
following administration of adrenocorticotrophic 
hormone (ACTH) [1]. Ovarian tumors can promote 
paraneoplastic syndromes related to altered tumor 
steroidogenesis [4,6,10,14]. By this moment, in dogs, 
there is only one ovarian tumor report, suggested to 
be a luteoma, associated do HAC in a Rottweiler bitch 
[17]. The aim of this work was to report an unpublished 
ovarian granulosa cell tumor associated with occult 
HAC in a Yorkshire Terrier bitch.
CASE
A 13-year-old female intact, Yorkshire Terrier 
dog was brought to the Hospital de Clínicas Veterinárias 
(HCV) of the  Universidade Federal do Rio Grande do 
Sul (UFRGS) due to discrete weight loss, polyuria and 
polydipsia, and irregular estrous cycle. At physical exami-
nation the patient showed tachypnea, halitosis and severe 
periodontal disease associated with submandibular lymph 
adenomegaly. Moreover, a bulged abdomen with ventral 
skin showing telangiectasis, alopecic and hypotrichotic 
areas, hyperpigmentation, and small punctiform calcino-
sis cutis focus were evident (Figure 1).
A minimum data base (complete blood count, 
serum biochemistry, urinalysis, urinary culture, and 
ultrasound) was obtained. Serum biochemistry after 12 
h fasting main results showed hyperalbuminemia (3.7 g/
dL – reference interval: 2.6 to 3.3 g/dL), hyperphospha-
tasia (371 U/L - reference interval: < 156 U/L), discreet 
hypertriglyceridemia (142 mg/dL - reference interval: 
32 to 138 mg/dL) and reduced serum creatinine (0.47 
mg/dL - reference interval: 0.5 to 1.5 mg/dL). Comple-
te blood count did not show any alteration. However, 
urinalysis showed urine specific gravity 1,022 g/L (re-
ference interval: > 1,035) without any other alteration. 
Also, there was no bacterial growth in urine culture.
Abdominal ultrasound revealed urinary bladder 
with thickened walls and hyperechoic kidneys, with 
corticomedullary definition loss. Left adrenal gland 
measure 1.72 x 0.7 cm while right adrenal gland measure 
2.11 x 0.84 cm, compatible with bilateral adrenomegaly. 
Yet, discrete hepatomegaly and biliary bladder filled by 
hyperechoic biliary sludge with suspended hyperechoic 
points became evident. Furthermore, at hypogastric 
abdomen a large hypoechoic heterogeneous mass, with 
cystic cavities, and measuring about 5.63 cm x 7.66 cm 
was identified. Therefore, a thoracic X-ray for metastasis 
investigation and an echocardiography were requested 
for a near future surgical planning. A discreet mitral 
valve insufficiency with preserved systolic function was 
documented at echocardiography, and no metastatic 
evidence was observed in pulmonary fields’ X-ray.
Due to elevated HAC suspicion promoted by 
bitch’s clinical picture, a LDDST was performed to inves-
tigate a possible PDH. All cortisol determinations were 
made by radioimmunoassay. The LDDST results showed 
a 1.49 µg/dL basal cortisol (reference interval: 0.5 to 6 µg/
dL), 4-h post-dexamethasone cortisol 0.39 µg/dL (refer-
ence interval: < 1 µg/dL), and 8-h post-dexamethasone 
cortisol 0.06 µg/dL (reference interval: < 1 µg/dL), con-
sonant with a negative PDH result. Because of the dog’ 
typical HAC picture, and owner financial scarceness for 
further hormonal evaluation, an occult HAC diagnosis 
was assumed by the medical team. Trilostane (Vetoryl®)1 
treatment was then started, at 1 mg/kg dose, each 12 h 
with food, aiming to prepare the patient for an exploratory 
laparotomy to investigate and remove the hypogastric 
abdominal mass identified at ultrasound.
One month after treatment start, an AST was 
performed to access adrenocortical reserve due trilostane 
treatment and treatment effectiveness, by means of an 
intravenous administration of 5 µg/kg synthetic ACTH 
(Synacthen® 250 µg/mL)2. To further test for occult HAC, 
17α-hydroxy-progesterone (17-OHP) concentration was 
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also measured after ACTH administration. The patient 
showed a 9.88 µg/dL basal cortisol (reference interval: 0.5 
to 6 µg/dL), 1-h post-ACTH cortisol 13.95 µg/dL (refer-
ence interval: 6 to 17 µg/dL, target range for patients in 
HAC medical treatment: 2 to 6 µg/dL), and post-ACTH 
17-OHP 7.59 ng/mL (reference interval for intact female: 
< 4.2 ng/mL). In the same clinical evaluation, the owner 
reported abdominal pain and additional abdominal bulge, 
associated with dermatological clinical signals persis-
tence as well as polyuria and polydipsia. Abdominal 
ultrasound was repeated and confirmed the presence of 
a mass with 5.63 cm x 7.66 cm at hypogastric abdomen. 
The patient was then set out for exploratory laparotomy. 
Trilostane therapy was interrupted 24 h prior surgery, 
and then recovered again 24 h after surgical intervention.
During surgery, a cranial mass at left ovary was 
localized and an ovary-hysterectomy was done. The 
material was sent for histopathological evaluation and 
showed a friable consistency, brownish color, and mea-
sure 8.5 cm x 7.0 cm x 4.5 cm. Uterine lumen has several 
cysts filled by a plentiful brown mucous material. At 
right uterine horn medium third, a polypoid-like nodule, 
measuring 2.0 cm x 2.0 cm, whitish, encapsulated, and 
firm at cut was also found (Figure 2). Histopathological 
evaluation revealed a granulosa cell tumor at left ovary 
(Figure 3A), associated with a leiomyoma, and cystic 
endometrial hyperplasia (Figure 3B).
Two weeks after surgery the patient come back 
to the hospital due to severe prostration and hyporexia. 
Polyuria and polydipsia achieved remission, and the bitch 
was showing pale mucous membranes. Blood samples 
were collected, and an AST was performed together with 
an abdominal ultrasound. A normocytic normochromic 
anemia was observed (erythrocyte 4.23 x106/mm3, 
hemoglobin 10.3 g/dL, hematocrit 33%, MCV 78 Fl, 
MCHC 31.2%) associated with a serum sodium of 149 
mEq/L (reference interval: 135-150 mEq/L), and a mild 
hyperkalemia of 5.8 mEq/L (reference interval: 3,5-5 
mEq/L), with a resultant 25:1 Na:K ratio (reference inter-
val: > 27:1). These results suggest hypoadrenocorticism 
occurrence. No other hematological (leukogram, platelets 
count) or serum biochemistry abnormalities (albumin 3 g/
dL, ALT 44 U/L, total cholesterol 139 mg/dL, creatinine 
0.66 mg/dL, alkaline phosphatase 50 U/L, urea 41 mg/
dL, and triglycerides 65 mg/dL) were documented. At 
abdominal ultrasound, a caudal cava vein thrombus was 
observed with partial blood flux interruption, liver con-
gestion and small amount of cavity free liquid. Immediate 
interruption of trilostane treatment was recommended, 
as well as hospital internment for fluids administration 
and overall stabilization of the patient. Despite that, the 
patient deceived in less than 48 hours, and a necropsy 
was not authorized by the owners. Lately, AST results 
showed a basal cortisol of 1 µg/dL (reference interval: 
0.5 to 6 µg/dL), one-hour post-ACTH cortisol 1.2 µg/
dL (reference interval: 6 to 17 µg/dL, target range for 
patients in HAC medical treatment: 2 to 6 µg/dL), and 
post-ACTH 17-OHP 0.16 ng/mL (reference interval 
for spayed female: < 1.6 ng/mL). The clinical picture 
associated with laboratory results confirmed the hypoa-
drenocorticism, and the 17-OHP overproduction control 
after ovary-hysterectomy.
DISCUSSION
A possible relationship between ovarian tu-
mors and HAC is being discussed for years in human 
medicine [14,18]. However, there is paucity of ovarian 
tumor case reports linked to endocrinopathies in vete-
rinary literature, and only one case of HAC associated 
with an ovarian luteoma in a Rottweiler was found 
[17]. Granulosa cell tumors are gonadal-stromal neo-
plasia originated from the sexual ovarian cordon and 
represent approximately 50% of bitches’ ovarian tu-
mors. These neoplastic cells can secrete estrogens and 
progestogens, among other steroid precursors, leading 
to paraneoplastic syndromes such as estrogen-related 
pancytopenia, progesterone-related diabetes mellitus, 
cystic endometrial hyperplasia, pyometra, and persis-
tent estrus. Furthermore, in over 20% of the cases, a 
malignant behavior became evident with metastatic 
disease in different organs [4,6,10].
In the present case, cystic endometrial hyperpla-
sia was found in post-mortem examination, and irregular 
estrus cycle was reported by the owners. Nevertheless, 
no evidence of metastasis was found in the imaging exa-
ms performed, or even other paraneoplastic syndromes 
besides occult HAC. However, the thrombus at caudal 
cava vein identified only post-surgery was a potential 
consequence of tumor invasion throughout phrenic-
-abdominal vein, and is considered a highly malignant 
behavior [6,10]. Other possible origin for the thrombus 
is the fact that Cushing dog’s tend to thromboembolic 
problems due to stimuli for coagulation factors and 
anticoagulant factors activity diminishment [13]. Un-
fortunately, the fact that the owners did not authorized 
necropsy make impossible to clear up this question.
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Steroid hormones have cholesterol as precursor, 
and the steroidogenesis to active hormones occurs at 
adrenal cortex and gonads. While in adrenal cortices cho-
lesterol is converted to glucocorticoids, mineralocorticoi-
ds, and androgens, the gonadal steroidogenesis produces 
estrogens, progestogens, and androgens [8]. Steroids 
plasma transport, including cortisol, occurs by means 
of specific binding proteins, and only free steroids can 
enter cells and activate hormone receptors. By this way, in 
cases with increased steroidal hormones secretion, more 
cortisol may become free of binding proteins, leading 
to HAC clinical manifestations, despite cortisol results 
within reference values in dynamic tests such as LDDST 
and AST [1,7]. This hypothesis is supported in the present 
case due to elevated 17-OHP concentration after ACTH 
stimulation. Serum progesterone concentrations correlate 
with 17-OHP serum concentration during luteal phase in 
women [5], and the same is expected in bitches. Isolated 
17-OHP elevations lost specificity for HAC diagnosis and 
may be elevated in patients in treatment with trilostane. 
However, the relevant reduction in 17-OHP after ovary-
-hysterectomy strongly supports the ovarian origin for 
these steroidal imbalance [1,3,5,7,9,12].
HAC diagnosis is based on the presence of 
typical clinical signals, laboratorial abnormalities, 
imaging, and pituitary-adrenal cortex axis function 
tests [2,3,5]. This particular patient did show many 
hypercortisolemic-related symptoms such as polyuria 
and polydipsia, abdominal enlargement, telangiectasis, 
skin atrophy and hyperpigmentation, hypotrichosis, 
and calcinosis cutis [7]. Indeed, this set of skin atrophy, 
telangiectasis and calcinosis cutis may be considered 
pathognomonic for HAC in dogs [2,7,8]. Moreover, 
some common laboratory abnormalities in dogs with 
HAC were documented in the present case (alkaline 
phosphatase activity elevation, hypertriglyceridemia, 
and reduced serum creatinine) [2,3]. Ultrasound findings 
also contributed for the HAC characterization due to 
hepatomegaly and bilateral adrenomegaly [2,3,7,8]. 
The LDDST is considered by many authors, and by the 
consensus of the American College of Veterinary Inter-
nal Medicine as the best screening teste for HAC. The 
test is highly sensitive; however, little specific. By this 
way, it is recommended that HAC diagnosis should be 
based mainly in the presence of clinical manifestations, 
laboratory abnormalities, and imaging, associated with 
compatible endocrine tests [2,3]. The diagnosis of occult 
HAC was assumed due to the patient’s clinical picture 
Figure 2. Uterine and ovarian macroscopic appearance after surgical 
removal. Large arrow: neoplastic formation poorly delimited at left 
ovarium’s cranial pole measuring 8.5 x 7.0 x 4.5 cm. Small arrow: whitish, 
encapsulated, polypoid-like nodule at right uterine horn measuring 2.0 x 
2.0 cm. Thin arrows: cystic hyperplasia disseminated over uterine horns.
Figure 1. Yorkshire Terrier bitch ventral view. Abdominal enlargement, 
telangiectasis, comedones, and hypotrichosis at physical examination.
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strongly suggestive of the disease, associated with a 
negative LDDST, followed by an elevated 17-OHP 
post-ACTH [1,2]. Moreover, Yorkshire Terrier is one of 
the most affected breeds with HAC in this region [15].
Granulosa cell tumor diagnose was provided 
only after exploratory laparotomy and histopathologic 
ovarian evaluation once this diagnostic approach is not 
possible by means of imaging [10]. Cystic endometrial 
hyperplasia diagnosed after surgery is a common parane-
oplastic syndrome related to granulosa cell tumors and is 
a frequent progesterone-related uterine disease in bitches 
[6,8]. The elevated 17-OHP concentration in this case 
supports an influence of the hormonal secretion profile of 
the tumor in endometrium leading to cystic hyperplasia.
Despite bilateral adrenal gland hyperplasia, the 
absence of post-mortem examination impeded pituitary 
adenoma investigation, or an eventual bilateral adreno-
cortical neoplasia. The LDDST response profile in this 
case was not compatible with functional adrenocortical 
neoplasia [2,7,8] and the documentation of bilateral 
enlargement by itself is not consistent with HAC. Adre-
nomegaly may be secondary to chronic activation of 
the hypothalamic-pituitary-adrenal axis secondary to 
chronic or degenerative diseases [2,7], as for example, a 
large abdominal neoplasia as documented in the present 
case. In contrast, exogenous progestins promote corti-
cotrophic negative feedback [2,8]. Whether endogenous 
progesterone overproduction would have the same effect, 
or negatively affect LDDST sensibility is unknow [2]. 
Likewise, the hypoadrenocorticism clinical picture, and 
deficient cortisol response in the AST two weeks after 
surgery, with trilostane treatment maintenance, give sup-
port to the granulosa cell tumor promoting a clinical HAC 
hypothesis due to the altered ovarian steroidogenesis.
A common trilostane side effect is hyperkale-
mia, independently of aldosterone suppression [9] as 
documented in the present case. Even though sodium to 
potassium ratio below 27:1 suggests mineralocorticoid 
deficiency, sodium concentration nearby the upper re-
ference range dismiss this hypothesis, once aldosterone 
deficiency is marked by hyperkalemia associated with 
hyponatremia [7,8]. Moreover, patients that suffer unila-
teral adrenalectomy for ACTH-independent HAC do not 
develop mineralocorticoid deficiency after surgery [7,8], 
a similar pathophysiologic scenario described herein. 
This argument is supported by the fact that the hypoa-
drenocorticism documented after surgery was marked by 
glucocorticoid deficiency after ovarian removal, and tri-
lostane treatment maintenance. A recent cohort study on 
patients that developed hypoadrenocorticism secondary 
to trilostane therapy did show that most patients last two 
or more years for this outcome [11]. Furthermore, rarely 
those reported cases occurred after only few weeks after 
trilostane starting as observed in the present case, despite 
some dogs did show hypoadrenocorticism only five days 
after therapy beginning [11]. Once AST performed be-
fore surgery showed that cortisol level were higher then 
desired, and that no trilostane change was proposed based 
on that, hypoadrenocorticism occurrence after surgery 
further indicate the granulosa cell tumor as the rascal.
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Figure 3. A- Ovarian granulosa cell tumor. Neoplastic tubular pattern proliferation with cystic multifocal formation [HE Obj. 200x]. B- Cystic endometrial 
hyperplasia. Multiple dilated endometrial glands filled by eosinophilic amorphous material [HE Obj. 100x].
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